ArticleCureus2025
Second-Degree Burns Following Intense Pulsed Light Therapy in a Patient With Fitzpatrick Skin Type IV: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intense pulsed light (IPL) therapy is widely used in cosmetic dermatology for the treatment of unwanted hair, vascular lesions, pigmentary disorders, and acne-related sequelae. We present a case of a male in his late 20s with Fitzpatrick skin type IV who sustained second-degree burns following IPL therapy for post-acne erythema performed by a non-medical operator. The patient developed erythema, blisters, and desquamation. He was treated with oral medications (acyclovir and cephalexin), corticosteroid ointment, and medicated powder dressings. Subsequent treatment included light-emitting diode (LED) therapy, picosecond laser sessions, and topical depigmenting agents. Significant improvement was noted after four months with minimal residual hyperpigmentation. This case highlights the risks associated with IPL treatment administered by untrained personnel and underscores the importance of professional oversight and patient-specific parameter adjustments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.